These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7545335)

  • 1. Changes of white blood cells, immunosuppressive acidic protein, and interleukin-2 receptor after open heart surgery.
    Chu SH; Hu RH; Lee YC; Chen KT
    Thorac Cardiovasc Surg; 1995 Apr; 43(2):94-8. PubMed ID: 7545335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
    Janiec K; Wajgt A; Kondera-Anasz Z
    Med Sci Monit; 2001; 7(1):93-8. PubMed ID: 11208501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
    Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
    Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the levels of serum-soluble interleukin-2 receptor after surgical stress.
    Murakami S; Sakata H; Tsuji Y; Okubo K; Takahashi T; Kikuchi M; Hirayama R
    Surg Today; 2003; 33(8):565-70. PubMed ID: 12884092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-pump coronary artery bypass grafting does not reduce lymphocyte activation.
    Blacher C; Neumann J; Jung LA; Lucchese FA; Ribeiro JP
    Int J Cardiol; 2005 Jun; 101(3):473-9. PubMed ID: 15907417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation.
    Markewitz A; Faist E; Lang S; Endres S; Fuchs D; Reichart B
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):15-24. PubMed ID: 8419695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
    Böhm M; Ittenson A; Klatte T; Schierbaum KF; Röhl FW; Ansorge S; Allhoff EP
    Folia Biol (Praha); 2003; 49(2):63-8. PubMed ID: 12779014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis?
    Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
    Ann Thorac Surg; 2006 Jul; 82(1):103-9. PubMed ID: 16798198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
    J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lymphocyte subsets and mitogen responsiveness following open-heart surgery and possible therapeutic approaches.
    Markewitz A; Faist E; Niesel T; Lang S; Weinhold C; Reichart B
    Thorac Cardiovasc Surg; 1992 Feb; 40(1):14-8. PubMed ID: 1385913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open heart surgery.
    Perttilä JT; Salo MS; Jalonen JR; Kuttila KT; Viinamäki O; Pulkki KJ
    Anesth Analg; 1994 Oct; 79(4):654-60. PubMed ID: 7943771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of leukocyte subsets in coronary artery bypass surgery: cardiopulmonary bypass versus 'off-pump' techniques.
    Diegeler A; Tárnok A; Rauch T; Haberer D; Falk V; Battellini R; Autschbach R; Hambsch J; Schneider P; Mohr FW
    Thorac Cardiovasc Surg; 1998 Dec; 46(6):327-32. PubMed ID: 9928852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness.
    Lahat N; Shtiller R; Zlotnick AY; Merin G
    Clin Exp Immunol; 1993 Jun; 92(3):482-6. PubMed ID: 8513579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.